A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/4dfc2852-ec06-4238-861b-ffbd9ccfe4f5
Dimension is a leading gene therapy company focused on discovering and developing new therapeutic products for people living with devastating rare diseases associated with the liver and based on the most advanced adeno-associated virus (AAV) delivery technology. The company is advancing multiple programs toward clinical development, including: programs addressing unmet needs for patients suffering from ornithine transcarbamylase (OTC) deficiency and glycogen storage disease type Ia (GSDIa), a collaboration with Bayer HealthCare in hemophilia A, and a wholly owned program in hemophilia B which is expected to enter clinical testing by the end of this year.
“We are proud to welcome Dimension Therapeutics to The Nasdaq Stock Market, and look forward to supporting the company as it brings to market the treatments in its R&D pipeline,” said Nelson Griggs, Executive Vice President, Listing Services, Nasdaq.
By listing on Nasdaq, Dimension Therapeutics joins many of the world’s largest and most revolutionary companies. Nasdaq is the exchange of choice for 89 percent of healthcare companies that have listed on the U.S. markets year-to-date.
The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular security or an overall investment strategy. Neither Nasdaq nor any of its affiliates makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Statements regarding Nasdaq-listed companies are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.
Nasdaq, Inc. (Nasdaq:NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today’s global capital markets. As the creator of the world’s first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world’s securities transactions. Nasdaq is home to more than 3,500 listed companies with a market value of approximately $9.5 trillion and more than 10,000 corporate clients. To learn more, visit: nasdaq.com/ambition or business.nasdaq.com.
The photo is also available via AP PhotoExpress.
CONTACT: Media Relations Contacts: Hilary Edelstein (646) 678- 2321 Hilary.Edelstein@nasdaq.com